구조모아 (StructureMoa)항암 chemical structure spider web
방문타깃 · 모달리티 · 임상 근거 · 비임상 맥락으로 최대 5개 프로그램을 나란히 비교합니다. · 다음 갱신 D-6 · 마지막 9월 2일
현재 선택: 1개 · 임상 갱신 필요 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | Technetium Tc-99m Sodium Pertechnetate (Technetium Tc-99m Sodium Pertechnetate) Endocyte·Metastatic Endometrial Carcinoma 7 trials |
|---|---|
Overview Program | Technetium Tc-99m Sodium Pertechnetate |
Overview Company | Endocyte |
Overview Modality | CGT |
Overview Target | Metastatic Endometrial Carcinoma |
Overview Indication | Metastatic Endometrial Carcinoma; Recurrent Endometrial Adenocarcinoma |
Overview Phase | PHASE_1 |
Overview Status | RECRUITING |
Overview Content status | Standard Database |
Overview Data Confidence | Data Confidence · Medium |
Overview Development Signal | Development Signal · Watch |
Overview Approval status | Investigational |
Toxicology Major finding | The impact of different computational assumptions in 131 I dosimetry for hyperthyroidism therapy.. The goal of the current study was to investigate the impact of different computational models on 131 I dosimetry prior to hyperthyroidism therapy. It was also aimed to highlight an accurate and cost-effective method for routine dosimetry of graves and toxic adenoma patients. A cohort of 45 patients w… |
Clinical Safety signal | The impact of different computational assumptions in 131 I dosimetry for hyperthyroidism therapy.. The goal of the current study was to investigate the impact of different computational models on 131 I dosimetry prior to hyperthyroidism therapy. It was also aimed to highlight an accurate and cost-effective method for routine dosimetry of graves and toxic adenoma patients. A cohort of 45 patients w… |
Clinical Program phase | PHASE_1 |
타깃 · 모달리티 · 임상 근거 · 비임상 맥락으로 최대 5개 프로그램을 나란히 비교합니다. · 다음 갱신 D-6 · 마지막 9월 2일
현재 선택: 1개 · 임상 갱신 필요 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | Technetium Tc-99m Sodium Pertechnetate (Technetium Tc-99m Sodium Pertechnetate) Endocyte·Metastatic Endometrial Carcinoma 7 trials |
|---|---|
Overview Program | Technetium Tc-99m Sodium Pertechnetate |
Overview Company | Endocyte |
Overview Modality | CGT |
Overview Target | Metastatic Endometrial Carcinoma |
Overview Indication | Metastatic Endometrial Carcinoma; Recurrent Endometrial Adenocarcinoma |
Overview Phase | PHASE_1 |
Overview Status | RECRUITING |
Overview Content status | Standard Database |
Overview Data Confidence | Data Confidence · Medium |
Overview Development Signal | Development Signal · Watch |
Overview Approval status | Investigational |
Toxicology Major finding | The impact of different computational assumptions in 131 I dosimetry for hyperthyroidism therapy.. The goal of the current study was to investigate the impact of different computational models on 131 I dosimetry prior to hyperthyroidism therapy. It was also aimed to highlight an accurate and cost-effective method for routine dosimetry of graves and toxic adenoma patients. A cohort of 45 patients w… |
Clinical Safety signal | The impact of different computational assumptions in 131 I dosimetry for hyperthyroidism therapy.. The goal of the current study was to investigate the impact of different computational models on 131 I dosimetry prior to hyperthyroidism therapy. It was also aimed to highlight an accurate and cost-effective method for routine dosimetry of graves and toxic adenoma patients. A cohort of 45 patients w… |
Clinical Program phase | PHASE_1 |
추천 비교
추천 비교